Created at	Source	Raw Value	Validated value
June 22, 2021, 2:30 a.m.	eu	The primary study parameter is the antibody based immune response to vaccination 28 days (t=3) after the second vaccination compared to controls. Participants will be classified as responders or non-responders	The primary study parameter is the antibody based immune response to vaccination 28 days (t=3) after the second vaccination compared to controls. Participants will be classified as responders or non-responders